This case outlines the rise and fall of Elizabeth Holmes and her company Theranos. The company offered a technology with the potential to revolutionize the blood drawing and analysis industry. After dropping out of Stanford and building the company over a ten-year period, Holmes moved out of “stealth mode” and was soon touted as an iconic entrepreneur and the new Steve Jobs. The publication of a Wall Street Journal article, however, highlighted irregularities with the technology and Theranos’s claims thus bringing company under closer examination.
Learning Objective
- Explore the role of the board in overseeing companies.
Keywords
Corporate Governance, Analysis
Settings
United States of America
Theranos, Manufacturing, Technology, Healthcare
2003-2016
Available Languages
English
Copyright Information
IMD retains all proprietary interests in its case studies and notes. Without prior written permission, IMD cases and notes may not be reproduced, used, translated, included in books or other publications, distributed in any form or by any means, stored in a database or in other retrieval systems. For additional copyright information related to case studies, please contact Case Services.
This case study is part of a series
